NASDAQ · Medical - Devices

Apyx Medical Corporation (APYX) Stock

$2.59 +9.75% NASDAQ: APYX Healthcare

Valuation

MetricValue
Price$2.59
Market Cap$109.07M
P/E Ratio-12.68
P/B Ratio10.36
P/S Ratio1.89
EPS (TTM)$0.00
52-Week High$5.08
52-Week Low$2.32
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-78.70%
ROA-14.14%
ROCE-6.84%
Gross Margin32.27%
Operating Margin-7.70%
Net Margin-14.78%
Debt/Equity3.72
Current Ratio4.83

Annual Financials (USD)

Metric20212022202320242025
Revenue$49.0M$45.0M$52.0M$48.0M$53.0M
Operating Profit$-14.0M$-24.0M$-17.0M$-19.0M$-6.0M
Net Profit$-15.0M$-23.0M$-19.0M$-23.0M$-11.0M
EPS$-0.44$-0.67$-0.54$-0.66$-0.27
Op Margin-29.8%-52.9%-33.0%-39.2%-12.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$69.0M$52.0M$79.0M$65.0M$67.0M
Total Liabilities$15.0M$14.0M$52.0M$51.0M$52.0M
Cash$31.0M$10.0M$44.0M$32.0M$32.0M
Borrowings$0$1.0M$39.0M$39.0M$39.0M

Latest News

HC Wainwright Initiates Apyx Medical at Buy With $7 Price Target MT Newswires · Jul 13, 2026 Apyx Medical Corporation (APYX): a High Growth Micro-Cap Stock Improving Cellulite and Skin laxity Insider Monkey · Jun 19, 2026 How The Apyx Medical (APYX) Story Is Shifting With AYON, GLP 1 Demand And 2026 Goals Simply Wall St. · Jun 1, 2026 Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway PR Newswire · May 27, 2026 What to Know About This Fund's $13.9 Million Exit From a Skyrocketing AI Power Play Motley Fool · May 21, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-10.0M$-20.0M$-5.0M$-18.0M$-8.0M
Investing Cash Flow$-1.0M$-2.0M$6.0M$-1.0M$-2.0M
Financing Cash Flow$0$0$-6.0M$0$0
Net Cash Flow$-11.0M$-21.0M$33.0M$-12.0M$0
Free Cash Flow$-11.0M$-21.0M$-6.0M$-19.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.14
EV / EBITDA-74.74
FCF Yield-10.01%
Quick Ratio4.53
Interest Coverage-0.63
Return 1Y114.21%
Return 3Y-30.13%
Return 5Y-53.83%

Ownership

Insiders Held13.61%
Institutions Held49.60%
Institutions Float Held57.42%
Institutional HolderSharesReport Date
Nantahala Capital Management, LLC3,440,3042026-03-31
Archon Capital Management LLC2,790,9232026-03-31
Royce & Associates LP2,611,2242026-03-31
Vanguard Capital Management LLC1,555,2722026-03-31
AIGH Capital Management LLC1,104,9702026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATOSAtossa Therapeutics, Inc. $2.44 +0.83% -0.54 $24.34M 0.00%
LUCDLucid Diagnostics Inc. $0.64 -1.86% -1.35 $121.71M 0.00%
NSPRInspireMD Inc. $0.52 +8.54% -1.17 $24.40M 0.00%
PDEXPro-Dex, Inc. $62.49 +0.45% 15.49 $199.52M 0.00%
QIPTQuipt Home Medical Corp. $3.65 +0.00% -14.85 $162.30M 0.00%

About Apyx Medical Corporation

Apyx Medical Corporation is led by CEO Charles D. Goodwin, employs 220 people, headquartered in US, publicly traded since 2019.

Apyx Medical Corporation (APYX) stock trades at $2.59 with a market capitalization of $109.07M. The stock is valued at a price-to-earnings (P/E) ratio of -12.68, price-to-book of 10.36, price-to-sales of 1.89. Over the past 52 weeks the stock has ranged between $2.32 and $5.08, and currently trades 49.0% below its 52-week high.

On profitability, Apyx Medical Corporation generates a return on equity (ROE) of -78.70%, return on capital employed of -6.84%, an operating margin of -7.70%, a net profit margin of -14.78%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides